Evidence map›Paper›PMID 40851773›Full record

ArticleAthletic training & sports health care2021

Substance Use Among Collegiate Athletes Versus Non-athletes.

Jonathan Charest, Michael A Grandner, Amy B Athey, David McDuff, Robert W Turner

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Athletic training & sports health care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Substance Use and Addiction in Athletes: The Case for Neuromodulation and Beyond.International journal of environmental research and public health · 2022
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jonathan CharestCentre for Sleep & Human Performance, Calgary, Alberta, Canada (JC); the School of Psychology, Laval University, Québec City, Québec, Canada (JC); the Department of Kinesiology, University of Calgary, Calgary, Alberta, Canada (JC); the Departments of Psychiatry (MAG) and Psychology (ABA), University of Arizona, Tucson, Arizona; the School of Medicine, University of Maryland, College Park, Maryland (DM); and the School of Medicine & Health Sciences, The George Washington University, Washington, DC (RWT).
Michael A GrandnerCentre for Sleep & Human Performance, Calgary, Alberta, Canada (JC); the School of Psychology, Laval University, Québec City, Québec, Canada (JC); the Department of Kinesiology, University of Calgary, Calgary, Alberta, Canada (JC); the Departments of Psychiatry (MAG) and Psychology (ABA), University of Arizona, Tucson, Arizona; the School of Medicine, University of Maryland, College Park, Maryland (DM); and the School of Medicine & Health Sciences, The George Washington University, Washington, DC (RWT).
Amy B AtheyCentre for Sleep & Human Performance, Calgary, Alberta, Canada (JC); the School of Psychology, Laval University, Québec City, Québec, Canada (JC); the Department of Kinesiology, University of Calgary, Calgary, Alberta, Canada (JC); the Departments of Psychiatry (MAG) and Psychology (ABA), University of Arizona, Tucson, Arizona; the School of Medicine, University of Maryland, College Park, Maryland (DM); and the School of Medicine & Health Sciences, The George Washington University, Washington, DC (RWT).
David McDuffCentre for Sleep & Human Performance, Calgary, Alberta, Canada (JC); the School of Psychology, Laval University, Québec City, Québec, Canada (JC); the Department of Kinesiology, University of Calgary, Calgary, Alberta, Canada (JC); the Departments of Psychiatry (MAG) and Psychology (ABA), University of Arizona, Tucson, Arizona; the School of Medicine, University of Maryland, College Park, Maryland (DM); and the School of Medicine & Health Sciences, The George Washington University, Washington, DC (RWT).
Robert W TurnerCentre for Sleep & Human Performance, Calgary, Alberta, Canada (JC); the School of Psychology, Laval University, Québec City, Québec, Canada (JC); the Department of Kinesiology, University of Calgary, Calgary, Alberta, Canada (JC); the Departments of Psychiatry (MAG) and Psychology (ABA), University of Arizona, Tucson, Arizona; the School of Medicine, University of Maryland, College Park, Maryland (DM); and the School of Medicine & Health Sciences, The George Washington University, Washington, DC (RWT).

Funding

Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive AdultsR01DA051321 · NIDA · UNIVERSITY OF ARIZONA · PI FANTRY, LORI E, GRANDNER, MICHAEL A · 2020 to 2024
$4.1M
Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) StudyR01MD011600 · NIMHD · UNIVERSITY OF ARIZONA · PI GRANDNER, MICHAEL A · 2018 to 2022
$4.1M
Cardiovascular and Metabolic Risk Factors Associated with Short Sleep DurationK23HL110216 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI GRANDNER, MICHAEL A · 2012 to 2016
$813k
NHLBI NIH HHS K23 HL110216NIDA NIH HHS R01 DA051321NIMHD NIH HHS R01 MD011600
6 · The paper itself

Abstract

Purpose: To supplement the literature on substance misuse by collegiate athletes by expanding the number of substances typically examined and include mental health symptom covariates related to both sleep and substance use. Methods: Substance use was assessed with the following item: "Within the last 30 days, on how many days did you use?" with a list of 17 substances. Multinomial logistic regression analysis examined each substance variable as outcome and athlete status as predictor. Results: Findings of the fully adjusted model indicated that compared to non-athletes, collegiate athletes were most likely to be past users of alcohol, occasional users of smokeless tobacco, alcohol, and steroids, and frequent users of smokeless tobacco. Conclusions: The significant differences shown between collegiate athletes and non-athletes may reflect differences in intentions to improve performance, pain management, and stress management. Future studies should seek to elucidate the underreported and self-reported phenomena among this population.

Identifiers

PMID40851773
PMCPMC12369985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.